Definitive Proxy Filed for $427.5M All-Cash Acquisition by Knox Lane
CCRN sits 77% above its 52-week low of $7.43.
Summary
Cross Country Healthcare filed its definitive proxy statement for the all-cash acquisition by Knox Lane for $13.25 per share, with the shareholder vote scheduled for July 16, 2026.
Key Events · M&A and Partnerships · CCRN
-
Definitive Merger Proxy Filed
Cross Country Healthcare filed its definitive proxy statement (DEFM14A) for the proposed all-cash acquisition by KL Criss Cross Intermediate, LLC, an affiliate of Knox Lane.
-
Acquisition Terms Confirmed
Shareholders will receive $13.25 in cash for each share of common stock. This represents an approximately 31% premium to the closing price on May 6, 2026, the day before the merger announcement.
-
Shareholder Vote Scheduled
A special meeting of stockholders is scheduled for July 16, 2026, to vote on the merger agreement and related proposals. The board of directors unanimously recommends voting 'FOR' the merger.
-
Expected Completion in Q3 2026
The parties expect to complete the merger in the third quarter of 2026, subject to shareholder and regulatory approvals.
Analysis · CCRN · Trade & Services
This definitive proxy statement (DEFM14A) formalizes the shareholder vote process for the previously announced all-cash acquisition of Cross Country Healthcare by Knox Lane for $13.25 per share. The board unanimously recommends the merger, which offers a significant premium to the pre-announcement trading price. This filing is a critical step towards the completion of a thesis-altering event for shareholders, as it provides the final details for the upcoming vote on July 16, 2026, and confirms the company's transition to private ownership.
At the time of this filing, CCRN was trading at $13.17 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $434.7M. The 52-week trading range was $7.43 to $14.99. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.